Interest Paid, Excluding Capitalized Interest, Operating Activities of Vitro Biopharma, Inc. from 31 Jan 2022 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Vitro Biopharma, Inc. annual and quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD history and change rate from 31 Jan 2022 to 31 Oct 2025.
  • Vitro Biopharma, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Jan 2025 was $4,220, a 14% decline year-over-year.
  • Vitro Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2025 was $5,142, a 74% decline from 2024.
  • Vitro Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $19,533, a 9.6% decline from 2023.
  • Vitro Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $21,610, a 64% decline from 2022.
Source SEC data
View on sec.gov
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Annual Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $5,142 -$14,391 -74% 01 Nov 2024 31 Oct 2025 10-K 13 Feb 2026 2025 FY
2024 $19,533 -$2,077 -9.6% 01 Nov 2023 31 Oct 2024 10-K 13 Feb 2026 2025 FY
2023 $21,610 -$38,092 -64% 01 Nov 2022 31 Oct 2023 10-K 28 Jan 2025 2024 FY
2022 $59,702 01 Nov 2021 31 Oct 2022 10-K 29 Jan 2024 2023 FY

Vitro Biopharma, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $4,220 -$674 -14% 01 Nov 2024 31 Jan 2025 10-Q 20 Mar 2025 2025 Q1
Q4 2023 $4,894 -$902 -16% 01 Nov 2023 31 Jan 2024 10-Q 20 Mar 2025 2025 Q1
Q4 2022 $5,796 +$2,877 +99% 01 Nov 2022 31 Jan 2023 10-Q 14 Mar 2024 2024 Q1
Q4 2021 $2,919 01 Nov 2021 31 Jan 2022 10-Q 14 Mar 2023 2023 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.